BACKGROUND: Elite controllers (EC) are a rare subset of HIV infected individuals who control viral load below 50 copies/ml of plasma without treatment. METHODS: Thirty four EC were studied. The slope of CD4 count change was available for 25 of these subjects. We assessed immune activation by measuring the percent of CD38+HLA-DR+CD8+ T cells in the EC group and comparing it with that in 24 treatment-naïve HIV disease progressors and 13 HIV uninfected healthy controls. RESULTS: Compared to HIV uninfected subjects, EC had higher percentages of CD38+HLA-DR+CD8+ T cells (p < 0.001) that was lower than that observed in progressors (p < 0.01). Fifteen of 25 EC had a slope of CD4 count change that was not significantly different from 0 while 3 had a positive and 7 a negative CD4 count slope. Immune activation did not distinguish EC subsets with stable/increasing versus declining CD4 counts. CONCLUSIONS: Elevated immune activation in ECs is not associated with a faster rate of CD4 decline.
BACKGROUND: Elite controllers (EC) are a rare subset of HIV infected individuals who control viral load below 50 copies/ml of plasma without treatment. METHODS: Thirty four EC were studied. The slope of CD4 count change was available for 25 of these subjects. We assessed immune activation by measuring the percent of CD38+HLA-DR+CD8+ T cells in the EC group and comparing it with that in 24 treatment-naïve HIV disease progressors and 13 HIV uninfected healthy controls. RESULTS: Compared to HIV uninfected subjects, EC had higher percentages of CD38+HLA-DR+CD8+ T cells (p < 0.001) that was lower than that observed in progressors (p < 0.01). Fifteen of 25 EC had a slope of CD4 count change that was not significantly different from 0 while 3 had a positive and 7 a negative CD4 count slope. Immune activation did not distinguish EC subsets with stable/increasing versus declining CD4 counts. CONCLUSIONS: Elevated immune activation in ECs is not associated with a faster rate of CD4 decline.
Authors: Miguel Goicoechea; Davey M Smith; Lin Liu; Susanne May; Allan R Tenorio; Caroline C Ignacio; Alan Landay; Richard Haubrich Journal: J Infect Dis Date: 2006-05-18 Impact factor: 5.226
Authors: Florencia Pereyra; Sarah Palmer; Toshiyuki Miura; Brian L Block; Ann Wiegand; Alissa C Rothchild; Brett Baker; Rachel Rosenberg; Emily Cutrell; Michael S Seaman; John M Coffin; Bruce D Walker Journal: J Infect Dis Date: 2009-09-15 Impact factor: 5.226
Authors: Janis V Giorgi; Robert H Lyles; Jose L Matud; Traci E Yamashita; John W Mellors; Lance E Hultin; Beth D Jamieson; Joseph B Margolick; Charles R Rinaldo; John P Phair; Roger Detels Journal: J Acquir Immune Defic Syndr Date: 2002-04-01 Impact factor: 3.731
Authors: Sophie Grabar; Hana Selinger-Leneman; Sophie Abgrall; Gilles Pialoux; Laurence Weiss; Dominique Costagliola Journal: AIDS Date: 2009-06-01 Impact factor: 4.177
Authors: Jason F Okulicz; Vincent C Marconi; Michael L Landrum; Scott Wegner; Amy Weintrob; Anuradha Ganesan; Braden Hale; Nancy Crum-Cianflone; Judith Delmar; Vincent Barthel; Gerald Quinnan; Brian K Agan; Matthew J Dolan Journal: J Infect Dis Date: 2009-12-01 Impact factor: 5.226
Authors: Ana E Sousa; Jorge Carneiro; Martin Meier-Schellersheim; Zvi Grossman; Rui M M Victorino Journal: J Immunol Date: 2002-09-15 Impact factor: 5.422
Authors: Yue Yang; Maha Al-Mozaini; Maria J Buzon; Jill Beamon; Sara Ferrando-Martinez; Ezequiel Ruiz-Mateos; Eric S Rosenberg; Florencia Pereyra; Xu G Yu; Mathias Lichterfeld Journal: AIDS Date: 2012-03-27 Impact factor: 4.177
Authors: R Camacho-Sandoval; P M Del Río Estrada; A Rivero-Arrieta; G Reyes-Terán; L C Bonifaz Journal: Clin Exp Immunol Date: 2014-12 Impact factor: 4.330
Authors: José M Benito; María C Ortiz; Agathe León; Luis A Sarabia; José M Ligos; María Montoya; Marcial Garcia; Ezequiel Ruiz-Mateos; Rosario Palacios; Alfonso Cabello; Clara Restrepo; Carmen Rodriguez; Jorge Del Romero; Manuel Leal; María A Muñoz-Fernández; José Alcamí; Felipe García; Miguel Górgolas; Norma Rallón Journal: BMC Med Date: 2018-02-28 Impact factor: 8.775
Authors: Fernanda H Côrtes; Hury H S de Paula; Gonzalo Bello; Marcelo Ribeiro-Alves; Suwellen S D de Azevedo; Diogo G Caetano; Sylvia L M Teixeira; Brenda Hoagland; Beatriz Grinsztejn; Valdilea G Veloso; Monick L Guimarães; Mariza G Morgado Journal: Front Immunol Date: 2018-07-11 Impact factor: 7.561
Authors: Julie Christine Gaardbo; Hans J Hartling; Andreas Ronit; Kristina Thorsteinsson; Hans Ole Madsen; Karoline Springborg; Lise Mette Rahbek Gjerdrum; Carsten Birch; Matthew Laye; Henrik Ullum; Åse Bengaard Andersen; Susanne Dam Nielsen Journal: PLoS One Date: 2013-05-16 Impact factor: 3.240
Authors: Nicole F Bernard; Zahra Kiani; Alexandra Tremblay-McLean; Sanket A Kant; Christopher E Leeks; Franck P Dupuy Journal: Front Immunol Date: 2017-08-24 Impact factor: 7.561